About
Entasis Therapeutics is a biopharmaceutical company developing small-molecule antibiotics and adjunctive therapies to treat serious Gram-negative bacterial infections, focusing on inhibitors to overcome beta-lactamase–mediated resistance.
Explore Entasis Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.